The new version, available today, provides enhanced support for controlled data entry processes, easier and faster data entry and analysis, and Intellectual Property (IP) protection capabilities. "We are seeing a unique and important shift in the pharma and biotech industries where companies are moving from a document-centric view of the enterprise to a data-centric view - a transition that requires R&D to streamline and adapt quickly to changing business processes," said Ruchi Mallya, Pharmaceutical Technology Analyst at Ovum. "Solutions such as E-WorkBook are making this task easier for researchers by changing the way data is captured, analyzed and reported, giving them flexibility in how they run their scientific experiments and reducing their time to access data."
Reducing the Burden of Regulatory Compliance
E-WorkBook is used in many regulated DMPK, Bioanalysis, Formulations, and Toxicology laboratories that require rigorous control of workflows and data entry processes. This latest version includes enhanced template intelligence features, including non-deletable items, enforced sequential data entry, granular drag-and-drop and full template version tracking, all of which reduce the cost and complexity of regulatory compliance. For example, the ability to search and find experiments that used a specific template name and version significantly improves traceability and problem resolution.
Increased Security and Speed
E-WorkBook now includes plug-and-play integration with digital signature infrastructures that enables researchers to even more easily protect their IP and conform to company policies. Version 8.2 is certified by SAFE-BioPharma, the pharmaceutical industry's signature standards body. Any SAFE-BioPharma compliant electronic identity system can be quickly and easily configured to work with E-WorkBook. Version 8.2 also includes performance improvements to curve fitting functions, pdf generation, data loading, search capabilities and chemistry queries.
Customer Requested Enhancements
This release includes significant enhancements to multistep chemical pathway generation, rendering and searching, which are of particular importance in Metabolite Identification and Process Optimization. A 'Print To' function, increased data exchange capabilities and enhanced analytical data capture and visualization are all features that scientists in the areas of method development and validation describe as class-leading.
"E-WorkBook continues to set the standard for ELNs and with this new version we once again raise the bar for functionality, speed and flexibility," said Glyn Williams, VP of Product Delivery at IDBS. "E-WorkBook has been deployed in R&D organizations across many industries and every day enables thousands of users to see more productive research and realize results faster. IDBS is committed to continually investing in its world-class products to meet the evolving needs of our customers as they strive to accelerate and streamline their research efforts."